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Purpose: To observed the imaging and pathological features of the glomangiopericytoma.
Experimental design: In this paper we report a typical case of glomangiopericytoma arising in the skull base area
and summarize the clinical manifestations, imaging and pathological features of such diseases.
Results: Immunohistochemical staining confirmed the tumor cells were strongly positive to Vim, SMA, MSA and
negative to CD31, CD34. Partial cells were positive to FVIII. The imaging can’t confirm the diagnosis but indicate the the
tumor has intact envelope.The cells in the tumor envelope is positive to Vim and negative SMA and FVIII. These
findings were compatible with glomangiopericytoma and the cells in the tumor envelope is not glomangiopericytoma
cells.
Conclusion: In view of the clinical and pathological features of the glomangiopericytoma, we believe that the surgery
is the best treatment so far and the tumor can be resected completely. The above results can be preliminary reason to
explain the low recurrence of such diseases.
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Glomangiopericytoma is belonged to a spectrum of
lesions which includes myofibromatosis, myofibroma,
infantile haemangiopericytoma and myopericytoma.
Glomangiopericytoma was first reported as heman-
giopericytoma [1], but this definition has been questioned
[2,3]. In recent years, the concept of hemangiopericytoma
has been evolving to myopericytoma because the spindle
cells show myoid differentiation with positivity for smooth
muscle actin [4]. Glomangiopericytoma have characteris-
tics which have a component of cells with golmus-type fea-
tures including cuboidal shape, distinct cell borders, clear
to eosinophilic cytoplasm and central round nuclei. The
etiology is not clear although past trauma, hypertension,
pregnancy and use of corticosteroids may be involved [5].
In the last 20 years, only four cases of patients with oral
and maxillofacial tumor in our hospital were diagnosed as
hemangiopericytoma and two cases of which were
myofibromatosis, one case was glomangiopericytoma, the* Correspondence: william5218@126.com
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article, unless otherwise stated.other can’t be classified clearly(Table 1). In this paper we
report a typical case of glomangiopericytoma arising in
the right skull base area and summarize the clinical mani-
festations, imaging and pathological features of such
diseases.Method
This study was approved by Institutional Ethic Commit-
tee Office of Shanghai Ninth People’s Hospital (reference
number: 2013(88)). Written informed consent was
obtained from the patient for the publication of this art-
icle and accompanying images.Result
Case report
A 55-year-old woman presented with a 2-month history
of right parotid area tumor and intermittency pain, and
the patient feel foreign body sensation in right
pharyngeal portion. Type-B ultrasonic revealed a solid
tumor possibly arising from the deep part of parotid
gland. The skin of the parotid gland was free of the
tumor. We performed the surgery within a month after
the first visit to our department, the patient claimed that. This is an Open Access article distributed under the terms of the Creative
ecommons.org/licenses/by/2.0), which permits unrestricted use, distribution,
the original work is properly cited. The Creative Commons Public Domain
org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Clinical information of patients with hemangiopericytoma
Disease site Age, y Sex
(Female, Male)




Bucca 65 Female hemangiopericytoma Vim(+),SMA(+), CD31(+), CD34(+) No No
Skull base area 55 Female glomangiopericytoma Vim(+),SMA(+), MSA(+), CD31(-),
CD34(-)
No No
Mandible gum 39 Male myopericytoma Vim(+),SMA(+), MSA(+), CD31(-),
CD34(-), Des(-)
No No
Dorsum of tongue 58 Female myopericytoma Vim(+),SMA(+), CD34(-), Des(-) No No
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size increased gradually. The border of the tumor is evi-
dent and the tumor has intact envelope but which bled
very easily, so we did not perform biopsy. With these clin-
ical characteristics and radiographic findings, we supposed
the tumor to be benign hypervascular tumor, such as
neurinoma, although the possibility of metastatic cancer
was not excluded. Considering the location, the tumor oc-
cupy the overall right skull base area and which oppress
the interal carotid artery, we concluded that the tumor
was resectable through submandibular incision and the
angle of mandible was cut off. The tumor don’t have obvi-
ously stem, and the tumor was removed.
Imaging characteristics
Enhancement CT showed a lesion consisting of about
6.2 cm × 4.9 cm × 2.3 cm soft tissue density in the theFigure 1 CT images. A is CT plain scan. B, C, D is enhanced CT scan. B is pladeep part of parotid gland and the lesions showed
marked heterogeneous enhancement. The right jugular
vein and lateral pharyngeal wall was oppressed and
shifted, the deep surface of mandibular ramus was
oppressed and attenuated (Figure 1). The CT diagnosis:
tumor in the parotid deep leaves which may be diag-
nosed as neuroma or Adenoid Cystic Carcinoma and the
MRI examination is recommended. Magnetic Resonance
shows a solid tumor with clear boundary and showed a
lobulated tumor, magnetic resonance T1W1 perform-
ance high-mix signal (Figure 2A). After T2W1 and fat
suppression show level of mixed signal (Figure 2B, C)
and Contrast-Enhanced Magnetic Resonance showed in-
homogeneous enhancement in the tumor and the tumor
envelope is rich in blood (Figure 2D, E). The diagnose of
MRI was tumor arising from parotid deep leaves and
can’t confirm the diagnosis.in scan image, C is coronal scan image and D is sagittal scan image.
Figure 2 MR images. A, B, C is MRI plain scan. A is transverse TIWI, B is the axial pressure grease T2WI and C is coronal T2W1. Figure D and E is
enhanced MRI, D is transverse T1W1 and E is coronal fat suppression T1W1.
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Histological examination of the tumor revealed the
tumor was rich in glomus-like round cells. Hematoxylin
and eosin (H&E) staining of the operative specimen
showed a variable numbers of vascular channels andFigure 3 Hematoxylin and eosin (HE) images. A (40×) and B (400×) is H
(400×) is HE staining of the operative specimen edge.perivascular concentric cellular growth (Figure 3A).
Glomus-like round cells were arranged around the
vessels. The tumor has a rich vasculature ranging from
slit-like sinusoidal spaces to dilated thin-walled vessels.
Nuclear pleomorphism is absent and mitotic figures areE staining of the operative specimen center section. C (40×) and D
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velope (Figure 3C, D). This constellation of findings is
characteristic of glomangiopericytoma (GPC). Immuno-
histochemical staining confirmed the tumor cells were
strongly positive to Vim, SMA, MSA (Figure 4A, B, C)
and negative to CD31, CD34 (Figure 4E, F). Partial cells
were positive to FVIII (Figure 4D). These findings were
compatible with glomangiopericytoma. The cells in the
tumor envelope is positive to Vim and negative SMA
and FVIII (Figure 5), the above results suggest that the
cells in the tumor envelope is not glomangiopericytoma
cells.
Discussion
Glomangiopericytoma has been diagnosed as heman-
giopericytoma in the past years [6]. HaemangiopericytomaFigure 4 Immunohistochemistry images of the tumor ceter. A (400×)
cells are positive to SMA. C (400×) shows that tumor cells are positive to M
E (400×) shows that partial tumor cells are negative to CD31. F (400×) showwere defined as a group of tumors that develop in the
head and neck region [7], and the WHO unified similar
concepts into the category of glomangiopericytoma in
2005. They have a better prognosis despite their simi-
larity to the conventional tumor, and all the four pa-
tients above mentioned have not recurrence. They
often have histological features that look different from
haemangiopericytomas if the tumor cells closely resem-
ble glomus cells and these tumor cells are characterized
by round, punched-out central nuclei and pale eosino-
philic cytoplasm. The term glomangiopericytoma or
sinonasal-type haemangiopericytoma is preferred to de-
scribe them. Many cases which mainly arising in the
nasal cavity, paranasal sinuses and other parts have
been reported in journals [6,8,9], but there has been no
previous report of glomangiopericytoma in the skullshows that tumor cells are positive to Vim. B (400×) shows that tumor
SA. D (400×) shows that partial tumor cells are positive to FVIII.
s that partial tumor cells are negative to CD34.
Figure 5 Immunohistochemistry images of the tumor edge. A (40×) shows the overall situation of the tumor margin. B (400×) shows that
the cells within the tumor envelope (showed by the arrow) are negative to Vim. C (400×) shows that the cells within the tumor envelope
(showed by the arrow) are negative to SMA. D (400×) shows that the cells within the tumor envelope (showed by the arrow) are negative
to FVIII.
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of the skull base area. It is worthy to note because it is
rare to find such tumors in that region. It is difficult to
differentiate the diagnosis from histologically dissimilar
lesions that include glomangioma, myopericytoma and
angioleiomyoma and differential diagnosis with pleo-
morphic adenoma of parotid gland, neurinoma, Adenoid
Cystic Carcinoma and tumor derived from the meninges
et al. In our case, the glomus like cells were arranged in a
concentric perivascular array with vimentin, SMA, MSA,
CD99, S-100, Bcl-2 positivity and CD31, CD34, CK9,
EMA, HMB45, Melan A negativity, which are the histo-
logical characteristics of glomangiopericytoma. There have
been more than 100 cases of hemangiopericytoma-like tu-
mors have been reported in the nasal cavity and perinasal
sinuses [9], The pathogenesis of glomangiopericytoma is
unclear. Although trauma, hypertension and long term
steroid use are were specuted to be possible causes of the
tumor [5], the patient denied such histories. The etiology
for this patient’s tumor is unclear. Further research into
the pathogenesis and prognosis of glomangiopericytoma is
needed.
Glomangiopericytoma is considered to be low malig-
nant tumors which have low propensity to metastasize, a
recurrence rate of 7% to 40%, and a 5-year survival of
88% or higher [10,11] and the patients undergoing sur-
gery in our part all have no recurrence. The abovephenomenon can get a preliminary explanation. As the
HE images show that the tumor has intact envelope and
there is clear boundaries between the tumor and sur-
rounding normal tissues (Figure 1C,D). The important
thing is that the cells in envelope is not tumor cells and
this can be proved by the immunohistochemical staining
(Figure 5B, D, E).
In summary, in view of the clinical and pathological
features of the glomangiopericytoma, we believe that the
surgery is the best treatment so far and the tumor can
be resected completely. Of crouse, the large sample
search is necessary.Competing interest
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